-
Daughter of a former England cricketer died from sepsis, pneumonia and Chron's disease after paramedics failed to alert doctors to her symptoms
17 Jun 2025 19:30 GMT
The tragic daughter of a former England cricketer would have survived if medics had treated her properly, a coroner ruled today.
Bethan James, 21, daughter of ex-England and Glamorgan batsman Steve James had visited hospital multiple times in the days …
-
Daughter of cricketer James would not have died with timely sepsis care
17 Jun 2025 15:46 GMT
ShareSave
Bethan James died at University Hospital of Wales
A student "would not have died" if her care and treatment had not been delayed, an inquest has found.
Bethan James, 21, from Cardiff, died on 8 February 2020 from a combination of sepsis …
-
Bethan had a brilliant and full life ahead of her but it was taken away. It could so easily have been avoided
17 Jun 2025 14:25 GMT
The family of 21-year-old Bethan James, whose death could have been avoided, have slammed a health board for failing to take accountability. The daughter of cricket star Steve James was admitted to hospital on February 8, 2020 and died on February 9.
An …
-
Global Humira Biosimilar Market To Reach $5.96 Billion By 2029 With A Growth Rate Of 12.6%.
17 Jun 2025 13:10 GMT
The Business Research Company's Global Humira Biosimilar Market To Reach $5.96 Billion By 2029 With A Growth Rate Of 12.6%.
LONDON, GREATER LONDON, UNITED KINGDOM, June 17, 2025 /EINPresswire.com/ --
The Business Research Company’s Latest …
-
Ileostomy Products Market Analysis 2025 – Insights for Long-Term Investment & Planning
17 Jun 2025 12:19 GMT
The Business Research Company’s Ileostomy Products Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, June 17, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The Ileostomy …
-
Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts
17 Jun 2025 11:51 GMT
SPY002 and SPY072 were well tolerated, exhibited PK that supports quarterly or less frequent dosing, and fully engaged TL1A through up to 20 weeks of follow-up; ~75 day half-life demonstrated, more than 3-fold greater than first-generation anti-TL1A …
-
Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients
17 Jun 2025 11:11 GMT
Celltrion, Inc., a leading biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved a new presentation of Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), in a 45mg/0.5mL solution in a single- …
-
Cricketer's daughter would've lived without delay
17 Jun 2025 10:49 GMT
ShareSave
Bethan James died at University Hospital of Wales
A student "would not have died" if her care and treatment had not been delayed, an inquest has found.
Bethan James, 21, from Cardiff, died on 8 February 2020 from a combination of sepsis …
-
Florida AG investigating patient charges, hospital billing practices
17 Jun 2025 05:30 GMT
FOX 13's Jordan Bowen talked with one patient who's been in and out of the hospital since 2017, and he shares her story.
TALLAHASSEE, Fla. - Knowing the full price of a medical procedure before you get it isn't always easy. In many cases, the …
-
The Best Time to Take Probiotics Supplements, According to Health Experts
17 Jun 2025 03:48 GMT
Health experts agree that there is no one best time to take a probiotic supplement.
The best time is when you'll remember to take it consistently.
Some people should not take probiotic supplements, so check with your healthcare team before taking them. …
About
© 1995-2025